Stigmatization is common in patients with non-alcoholic fatty liver disease and correlates with quality of life.
Marta CarolMartina Pérez-GuaschElsa SolàMarta CerveraSara MartínezAdrià JuanolaAnn T MaEmma AvitabileLaura NapoleoneElisa PoseIsabel GrauperaMaria HonrubiaMarko KorenjakFerràn TorresPere GinèsNúria Fabrellasnull nullPublished in: PloS one (2022)
Perceived stigmatization is common among patients with NAFLD independently of disease stage, is associated with impaired quality-of-life, and may be responsible for stereotypes, discrimination, shame, and social isolation, which may affect human and social rights of affected patients.